4-Bromo-2,5-dimethoxyphenylisopropylamine, a new centrally active amphetamine analog.
Alexander T. Shulgin, Thornton W. Sargent, C. Naranjo
Study at a glance
AI-extracted from the abstract| Characteristics | Clinical evaluation Peer reviewed |
|---|---|
| Interventions | 4-bromo-2 5-dimethoxyphenylisopropylamine |
| Key points | The compound enhanced emotional and intellectual perception without perceptual distortions, suggesting potential as an adjunct to psychotherapy. |
Abstract
A new centrally active halo-amine, 4-bromo-2,5 dimethoxyphenylisopropylamine, is described. In clinical evalua tion it proved to enhance effectively both emotional and in tellectual perception, without the imagery and perceptual distortions commonly encountered with many of the chemically related psychotomimetics. These properties suggest a potential valuable role in conjunction with psychotherapy.
Citations in the library
Cited by 11
- Effect of Hallucinogens on Unconditioned Behavior Current Topics in Behavioral Neurosciences 2016
- Structure–activity relationships of serotonin 5‐HT2Aagonists Wiley Interdisciplinary Reviews Membrane Transport and Signalling February 28, 2012
- Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs Natural Product Reports 2014
- Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug. Drug Testing and Analysis July 1, 2013
- Synthesis of 123I‐labelled 4‐iodo‐2, 5‐dimethoxyphenylisopropylamine Journal of Labelled Compounds and Radiopharmaceuticals 1978
and 6 more in the library